Skip to main content
search
Category

Membership News

Membership NewsMembership News Archive

BIVDA responds to integrated, rules-based medtech pathway consultation

NHS England and NICE have launched a consultation on a proposed integrated, rules-based pathway for the evaluation, funding, and commissioning of medical technologies. It's been recognised after years of system-wide feedback that the current process is challenging for our established members and even more so for new entrants. It also demonstrates their understanding around a marked difference in approach between…
Ben Kemp
June 12, 2024
Membership NewsMembership News Archive

Examining the health and life science pledges in the Conservative and Lib Dem Manifestos

On Monday, the Lib Dems were the first of the three major parties to release their manifesto. Owing to Ed Davey's personal connection, the document focused heavily on social care. BIVDA is pleased to see the Lib Dems' pledge to review diagnostic provision across the NHS and implement a new ten-year Strategic Diagnostics Plan. This recognises the continued importance of…
Ben Kemp
June 12, 2024
Membership NewsMembership News Archive

Supply your products to ReMed Conference 2024

Professor Rahimifard, Professor of Sustainable Engineering at Loughborough University, will be a guest speaker at the Environmental Working Party in September and will be talking about the ReMed, a collaboration between Leeds and Loughborough Universities. He would like to ask whether any members be willing to forward a small sample of in vitro diagnostics products to to the RedMed conference.…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

Get a 20% discount on BS EN ISO 20916

  BSI has recently launched BS EN ISO 20916. The standard defines good practice for clinical performance studies of IVD medical devices. BIVDA members can get a 20% discount on this standard by entering SHOBVIDA20 at the checkout. BS EN ISO 20916 It’s critical that clinical performance studies consistently produce data of the highest quality so that safe healthcare decisions…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

BIVDA attend Health Innovation North Conference 2024

Formed from the four regional Health Innovation Networks (HINs), the Health Innovation North team held its first conference in Liverpool on 6th June. Pulling together senior leaders from across the NHS, stakeholders, entrepreneurs, and patient representatives, the conference looked to champion the role of innovation in improving health outcomes. BIVDA's Angela Douglas and Paul Fisher attended. Angela said “Having started…
Ben Kemp
June 11, 2024
Membership NewsMembership News Archive

BIVDA cited in Health and Social Care Committee’s Future Cancer Inquiry findings

The Health and Social Care Committee, a cross-party group of parliamentarians, have released the findings of their 15-month long Future Cancer Inquiry, citing BIVDA’s contribution. The inquiry examined how to improve the treatment, diagnosis and prevention of cancer. Chair Steve Brine Steve Brine MP wrote to the Secretary of State for Health, setting out five key areas for action and…
Ben Kemp
June 5, 2024
Membership NewsMembership News Archive

Election Round-Up: health pledges

As members will doubtless be aware, the general election campaign has kicked off. While manifestos will not be fully launched until next week - our sources believe Labour's will be unveiled on 13 June - major parties have been trailing their pledges. We will examine some of the health promises which have already been announced. Labour has pledged to eliminate…
Ben Kemp
June 5, 2024
Membership NewsMembership News Archive

MedTech Europe Forum – Vienna

Paul Fisher visited Vienna for this year’s MTE Forum, and found much for the diagnostic industry to be sunny about – despite some storms. Bringing together industry, stakeholders, and trade associations from across Europe, the forum offered expert speakers, insightful presentations, and significant networking opportunities. A number of BIVDA members were present. Paul said: “Europe still offers much to MedTech…
Ben Kemp
June 4, 2024
Membership NewsMembership News Archive

Steering diagnostic innovation to address the unmet needs in managing lung infections in people with cystic fibrosis

On June 5th 2024, the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections and exacerbations in CF. The CF AMR Syndicate together with the Newcastle NIHR HealthTech Research Centre (HRC), have undertaken extensive engagement with a broad range of experts across…
Ben Kemp
June 4, 2024
Close Menu